Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antineoplastics agents > Imatinib Mesylate
Imatinib Mesylate
Inquiry
| Post Date: | Nov 02,2013 |
| Expiry Date: | May 01,2014 |
| Detailed Description: |
Cas No. :220127-57-1
Payment Method: T/T Imatinib Mesylate CAS #: 220127-57-1 M.W.: 589.71 M.F.: C30H35N7O4S Description: White crystalline powder. Usage: A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia and certain forms of acute lymphoblastic leukemia. Standard: Enterprise standard |
| CAS Registry Number: | 220127-57-1 |
| Synonyms: | ;Glivec;gleevec;imatinib methanesulfonate;imatinib mesilate;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;Imatinibmesylate;Imatinib mesylate(Alpha form); |
| Molecular Formula: | C30H35N7O4S |
| Molecular Weight: | 589.71 |
| Molecular Structure: | 
|
| Company: | Jinan Sante Chemical Co.,Ltd. [ China ] |
| Contact: | Sammi Wang |
| Tel: | +86-13256710004 |
| Fax: | |
| Email: | jqintlsammi@hotmail.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
